FOLD

FOLD is currently trading as a high-conviction merger arbitrage play following BioMarin's December 2025 agreement to acquire the company for $14.50 per share. The 'Quiet Storm' signal and ultra-low annualized volatility (3.7%) confirm the stock is effectively pegged to the deal price, acting as a defensive 'merger bond' amidst the broader Tech selloff. While the macro regime screams 'Caution,' FOLD's relative strength is driven by the shrinking deal spread (~1.6%) and the flight to non-correlated assets.